Success Metrics

Clinical Success Rate
83.3%

Based on 10 completed trials

Completion Rate
83%(10/12)
Active Trials
0(0%)
Results Posted
10%(1 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_4
3
23%
Ph phase_3
3
23%
Ph phase_1
5
38%
Ph not_applicable
2
15%

Phase Distribution

5

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
5(38.5%)
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
3(23.1%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(10)
Terminated(3)

Detailed Status

Completed10
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (38.5%)
Phase 33 (23.1%)
Phase 43 (23.1%)
N/A2 (15.4%)

Trials by Status

withdrawn18%
completed1077%
terminated215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13